TIM
ABMD

Tortoise Investment Management’s Abiomed Inc ABMD Stock Holding History

Tortoise Investment Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-14
Closed -$4K – 651
2019
Q2 		$4K Hold
14
– – ﹤0.01% 526
2019
Q1 		$4K Buy
+14
New +$4.65K ﹤0.01% 516

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Tortoise Investment Management's ABMD Position: Q3 2019 in Review

Tortoise Investment Management sold out of Abiomed Inc (ABMD) in Q3 2019, closing a stake of 14 shares — an estimated $4K sold.

Tortoise Investment Management first reported a position in ABMD in Q1 2019 and held it in 2 quarters. The position peaked at $4K in Q2 2019. 443 funds tracked by Wall St. Rank hold ABMD as of Q3 2019.

  • Tortoise Investment Management reported no remaining Abiomed Inc position as of Q3 2019 after selling out during the quarter.
  • Tortoise Investment Management sold 14 Abiomed Inc shares in Q3 2019, an estimated $4K.
  • Tortoise Investment Management first reported a position in Abiomed Inc in Q1 2019 and held it in 2 quarters.
  • Tortoise Investment Management's Abiomed Inc position peaked at $4K in Q2 2019.
  • 443 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2019.

Based on Tortoise Investment Management's 13F filing for Q3 2019, filed 6 Nov 2019.